Unregistered User If this is not your name, click here.
		Contact Us | Order Now | Journals | Bookstore | Register a colleague
	Select a ChannelAcneAIDS and HIVAllergy OtherAlzheimer'sAnaesthesiology OtherAngina Pectoris/MIAnxietyArthritis OtherAsthmaBack PainBacterial InfectionsBladder CancerBone Marrow TransplantationBreast CancerCardiology OtherCataractCell TransplantationCervical CancerCholesterol/Lipid disordersCirrhosisClinical PharmacologyColorectal CancerCongestive Heart FailureContact DermatitisContraceptionCOPDCystic FibrosisDental and Oral DisordersDepressionDermatology OtherDiabetesDialysisEating DisordersElbowEmergency MedicineEndocrinology OtherEpilepsyErectile DysfunctionFibromyalgiaGastro OtherGeneticsGenitourinary OtherGeriatricsGERD/GastritisGlaucomaH. Pylori/UlcerHaematology OtherHair LossHeadachesHepa/Biliary OtherHepatitisHipHRTHypertensionIBDImmunologyInfectious OtherInfertilityIntensive CareIrritable Bowel SyndromeKneeLeukemiasLiver CancerLung CancerLupusLymphomasMelanomaMenopauseMultiple Sclerosis Nephrology OtherNeurologic OtherNutritional / Metabolic OtherOb/Gyn OtherObesityOncology OtherOphth. OtherOphthalmic SurgeryOrgan TransplantationOrthopaedics OtherOsteoarthritisOsteoporosisOtitisOtorhino. OtherOvarian CancerPaediatricsPainPancreatic CancerParkinson'sPregnancyProstate CancerPsychiatry OtherPulmonary OtherRadiologyRenal CancerRenal FailureRespiratory InfectionsRheumatoid arthritisRheumatology OtherRhinitisSchizophreniaShoulderSleep ApnoeaSleep DisordersSpineStrokeSTDsSurgeryThyroid DisordersTransfusionTransplant Surgery OtherTraumaUrinary IncontinenceUrinary tract infectionsVaccinologyVascular DisordersViral Infections

SEARCH   News Bookstore Medline The Web Meetings & Congresses Complete Doctor's Guide    EXPLORE :    All News   All Webcasts   All Cases   All Meetings & Congresses   All Medical Resources New drugs / indications English Dictionary Medical Dictionary Thesaurus Warning | Privacy | Awards  Favourite Journals  Click here to choose your favourite journals  Favourite Sites  Click here to choose your favourite sites  Languages  Select languageEnglishFrançais

Zadaxin (Thymalfasin) Approved For Hepatitis C In Mexico, Peru, Sri Lanka SAN MATEO, CA -- September 28, 2000 -- SciClone Pharmaceuticals announced that it has received an issued patent in Mexico for the use of the Company's lead drug, Zadaxin (thymalfasin), for the treatment of hepatitis C. SciClone also announced that Peru has expanded Zadaxin's approval to include the treatment of hepatitis C as well as the previously approved hepatitis B. In Latin America, Zadaxin is approved for sale in Mexico, Peru, Argentina and Venezuela. Approved indications include hepatitis B, hepatitis C and as a viral vaccine adjuvant for patients with weakened immune systems. "The Mexican hepatitis C patent is of particular significance as Mexico is our first North American market and clearly one of the most important Latin American market," said Donald R. Sellers, SciClone's President and Chief Executive Officer. "Our Zadaxin launch in Mexico is in full swing." Sellers noted that SciClone will be a major participant at the 16th Latin American Congress of Hepatology held this year in Mexico throughout the first week of October. The upcoming congress will be the Company's most significant medical education opportunity to date with Latin American physicians, researchers and hepatitis opinion leaders. SciClone also announced that Zadaxin approval has been expanded from hepatitis B to include hepatitis C in Sri Lanka. Zadaxin is approved for sale in 20 countries, principally for the treatment of hepatitis B and hepatitis C and as a vaccine adjuvant for patients with weakened immune systems. Related Links: Zadaxin (thymalfasin) and SciClone Pharmaceuticals. E-mail this page to a friend or colleague! To print, use this version